ClearPoint Neuro, Inc. — Director's Dealing 2025

Mar 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2025-03-12

Reporting Person: BURNETT JOSEPH MICHAEL (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-12	Common Stock	M	42414	—	Acquired	313537	Direct
2025-03-12	Common Stock	F	23405	$13.18	Disposed	290132	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-12	Restricted Stock Units	$	M	42414	Disposed		Common Stock (42414)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F2: Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.